Somatropin biosimilar - Amega Biotech

Drug Profile

Somatropin biosimilar - Amega Biotech

Alternative Names: recombinant human growth hormone - Amega Biotech

Latest Information Update: 15 Aug 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Amega Biotech
  • Class Growth hormones; Hormonal replacements
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase Unknown Growth disorders; Short stature; Somatotropin deficiency

Most Recent Events

  • 15 Aug 2013 Investigation in Growth disorders in Argentina (Parenteral)
  • 15 Aug 2013 Investigation in Short stature in Argentina (Parenteral)
  • 15 Aug 2013 Investigation in Somatotropin deficiency in Argentina (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top